10.1371/journal.pone.0173726 2 AignerT.SderS.GebhardP
But the market is also complex, rapidly evolving, and not without risks
Events were defined as the time from randomization to the occurrence of progression to unresectable melanoma before surgery, disease recurrence, or death due to melanoma or treatment.[21] The median duration of follow-up was 10.6 months in both groups
By integrating Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) , practices can bridge this gap transforming a simple prescription into a comprehensive, billable, and life-changing metabolic program
This observation led to a study where GLP-1 was given to obese patients with T2DM and showed improved glycemic control with no side effects, establishing a proof-of-concept for GLP-1 agonists, which over time led to their use in the treatment of T2DM patients [21]